Please login to the form below

Not currently logged in

skin cancer

This page shows the latest skin cancer news and features for those working in and with pharma, biotech and healthcare.

CHMP recommends new Keytruda dosing schedule

CHMP recommends new Keytruda dosing schedule

Importantly, the positive CHMP opinion supports the approval of a six-week dosing option across all eight approved Keytruda monotherapy indications in Europe, spanning five cancer types. ... It made history by becoming the first FDA-approved drug

Latest news

More from news
Approximately 19 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • Digital health Digital health

    What digital health has delivered to date is amazing. The examples are legion: an application which can differentially diagnose lesions on skin with 20-30 times more accuracy than a doctor ... when it comes to skin cancer, or HealthTap’s Dr AI which

  • Case study: Skin cancer awareness

    Skin cancer is on the increase. It is one of the most common cancers in the 15-24 age group and a significant cause of death. ... Posters and leaflets do not get through to younger people; at this age they feel invincible and believe skin cancer will

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • CytomX appoints Rachel Humphrey chief medical officer CytomX appoints Rachel Humphrey chief medical officer

    Before her time at AZ and Eli Lilly, Humphrey was also VP of product development at Bristol-Myers Squibb where she led all aspects of clinical development of the skin-cancer

  • Kite Pharma appoints Zelboraf scientist as CMO Kite Pharma appoints Zelboraf scientist as CMO

    Keith Nolop joins US cancer biotech from Plexxikon. Dr Keith Nolop, one of the chief scientists behind the development of Roche's personalised skin cancer drug Zelboraf, has been appointed chief ... At Plexxikon, he also led the filing of eight

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Is fear an effective driver of behaviour change?

    Liz, who knows she has a high risk for skin cancer due to family history and skin type, will be more likely to apply sun cream (provided it is easy for ... Leo, who knows he has a lower risk of skin cancer, or for whom the cost or convenience of applying

  • When is sun safety doing more harm than good?

    New figures from  Cancer Research UK  warn that people over 65 are around seven times more likely to develop malignant melanoma - a type of skin cancer - compared to 40 years ago. ... Thankfully campaigns from charities such as Cancer Research UK

  • Market Insights Can Deliver a Better Patient Experience

    Cancer Research UK’s Sunsmart campaign knew from their research that health safety messages were not going to change the behavior of young people who use sunbeds to tan their skin. ... This audience are more concerned about their looks than about the

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....